Veeva Crossix
Gain Full Visibility into
Customer Engagement
View field force data and marketing insights in one
platform to better assess impact across channels.
Veeva CRM Boost
HCP engagement data from Veeva CRM, the industry’s leading field force management software, is now available in the Crossix suite of measurement applications.
A comprehensive view of field force and marketing efforts
Understand how personal and non-personal promotion work together to drive HCP education and prescribing.
Link HCP engagement to DTC campaigns
Optimize consumer campaigns to drive patients to field-engaged HCPs.
Free for Crossix customers using Veeva CRM
Enables senior leadership to measure, track, and optimize integrated marketing efforts.
Industry Insights
The healthcare marketing industry is rapidly evolving. Read more about how today’s news stories will impact your business.
Bayer Leverages Patient Marketing Data to Drive HCP Engagement
Learn how Bayer partnered with Veeva Crossix to leverage patient marketing data to drive HCP engagement.
Crossix Measurement Suite Innovation Guide
Learn about the recent innovations in the Crossix Measurement Suite, all designed for sustainable measurement and providing meaningful insights that can drive more informed marketing decisions.
Bringing Patient Data into Your Omnichannel Strategy
Learn how brands can fill critical gaps in their omnichannel engagement strategy by connecting privacy-safe patient engagement data to HCP interactions.
2023 Trends in HCP Omnichannel Engagement Report
Focused field force and marketing synchronization can lead to better HCP engagement and marketing effectiveness.
Sanofi: Omnichannel Excellence Across HCP and DTC Marketing
Stephanie Douglas, director, omnichannel media, Sanofi, shares insights on how to create a more cohesive approach to HCP and DTC marketing.
Synchronizing Digital Media with Field Boosts Marketing Effectiveness
Brands that coordinate HCP marketing and field activity maximize their efforts across the organization and increase marketing effectiveness by 23%